Cargando…
Soluble Immune-Related Proteins as New Candidate Serum Biomarkers for the Diagnosis and Progression of Lymphangioleiomyomatosis
BACKGROUND: The goal of this study was to analyze serum from lymphangioleiomyomatosis (LAM) patients and healthy controls to identify novel biomarkers that could shed light on disease diagnosis and pathogenesis. METHODS: From April 2017 to October 2019, qualified serum samples were obtained to explo...
Autores principales: | Liu, Xuefei, Xu, Yanping, Wu, Xueying, Liu, Yanpu, Wu, Qiang, Wu, Jialiang, Zhang, Henghui, Zhou, Min, Qu, Jieming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923288/ https://www.ncbi.nlm.nih.gov/pubmed/35300340 http://dx.doi.org/10.3389/fimmu.2022.844914 |
Ejemplares similares
-
Lymphangioleiomyomatosis: Searching for potential biomarkers
por: Revilla-López, Eva, et al.
Publicado: (2023) -
VEGF-D: a novel biomarker for detection of COVID-19 progression
por: Kong, Yaxian, et al.
Publicado: (2020) -
Serum Soluble B Cell-Activating Factor Is a Non-Invasive Biomarker of Antibody-Mediated Rejection in Kidney Allograft With Satisfactory Risk Stratification Performance But Negligible Diagnostic Value
por: Wu, Shenghui, et al.
Publicado: (2022) -
Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis
por: Hu, Congqi, et al.
Publicado: (2022) -
Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis
por: Hirose, Masaki, et al.
Publicado: (2019)